Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Rozengurt

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Physiology (Bethesda, Md.)|March 2, 2011
Protein kinase D signaling: multiple biological functions in health and diseaseEnrique Rozengurt
Trends in Endocrinology and Metabolism: TEM|March 15, 2002
Neuropeptides as growth factors for normal and cancerous cellsEnrique Rozengurt
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 20, 2006
Taste receptors in the gastrointestinal tract. I. Bitter taste receptors and alpha-gustducin in the mammalian gutEnrique Rozengurt
Journal of Cellular Physiology|September 6, 2007
Mitogenic signaling pathways induced by G protein-coupled receptorsEnrique Rozengurt
Frontiers in Physiology|October 9, 2014
Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cellsEnrique Rozengurt
World Journal of Gastroenterology|May 7, 2019
Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer developmentEnrique Rozengurt, Guido Eibl
Cancer Metastasis Reviews|June 18, 2021
Metformin: review of epidemiology and mechanisms of action in pancreatic cancerGuido Eibl, Enrique Rozengurt
Nature Reviews. Gastroenterology & Hepatology|October 29, 2024
Bitter taste receptors as sensors of gut luminal contentsCatia Sternini, Enrique Rozengurt
Cancers|October 23, 2021
Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug ResistanceEnrique Rozengurt, Guido Eibl
Experimental Cell Research|October 22, 2003
Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cellsChintda Santiskulvong, Enrique Rozengurt
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Physiology (Bethesda, Md.)|March 2, 2011
Protein kinase D signaling: multiple biological functions in health and diseaseEnrique Rozengurt
Trends in Endocrinology and Metabolism: TEM|March 15, 2002
Neuropeptides as growth factors for normal and cancerous cellsEnrique Rozengurt
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 20, 2006
Taste receptors in the gastrointestinal tract. I. Bitter taste receptors and alpha-gustducin in the mammalian gutEnrique Rozengurt
Journal of Cellular Physiology|September 6, 2007
Mitogenic signaling pathways induced by G protein-coupled receptorsEnrique Rozengurt
Frontiers in Physiology|October 9, 2014
Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cellsEnrique Rozengurt
World Journal of Gastroenterology|May 7, 2019
Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer developmentEnrique Rozengurt, Guido Eibl
Cancer Metastasis Reviews|June 18, 2021
Metformin: review of epidemiology and mechanisms of action in pancreatic cancerGuido Eibl, Enrique Rozengurt
Nature Reviews. Gastroenterology & Hepatology|October 29, 2024
Bitter taste receptors as sensors of gut luminal contentsCatia Sternini, Enrique Rozengurt
Cancers|October 23, 2021
Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug ResistanceEnrique Rozengurt, Guido Eibl
Experimental Cell Research|October 22, 2003
Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cellsChintda Santiskulvong, Enrique Rozengurt
Pageof 16